| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/01/2007 | WO2007013627A1 Therapeutic agent for b-lymphoma and hodgkin lymphoma |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013391A1 Interferon-inducible molecule ips-1 |
| 02/01/2007 | WO2007013083A2 Complement c3a derived peptides and uses thereof |
| 02/01/2007 | WO2007012944A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/01/2007 | WO2007012449A1 Frizzled 9 as tumour marker |
| 02/01/2007 | WO2006122257A3 Nebulization of monoclonal antibodies for treating pulmonary diseases |
| 02/01/2007 | WO2006116260A3 Modulation of antibody effector function by hinge domain engineering |
| 02/01/2007 | WO2006116002A3 Tgf beta 1 specific antibodies |
| 02/01/2007 | WO2006096490A8 ANTI-MAdCAM ANTIBODY COMPOSITIONS |
| 02/01/2007 | WO2006091326A8 Anti-prl-3 antibodies and methods of use thereof |
| 02/01/2007 | WO2006082406A3 Human antibodies and proteins |
| 02/01/2007 | WO2006066229A3 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 02/01/2007 | WO2006033688A8 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses |
| 02/01/2007 | WO2005118622A3 Naturally processed measles virus peptides eluted from class ii hla molecules |
| 02/01/2007 | WO2005117967A3 Anti-il-9 antibody formulations and uses thereof |
| 02/01/2007 | WO2005077082A3 INHIBITING CAV3 ISOFORMS AND THE δ25B SPLICE VARIENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| 02/01/2007 | WO2005072263A3 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | WO2004078923A3 Pyk2 crystal structure and uses |
| 02/01/2007 | WO2004024869A3 Cancer associated antigens, sga-56m and sga-56mv, and uses thereof |
| 02/01/2007 | WO2003105773A3 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026502 Specificity exchangers that redirect antibodies to a pathogen |
| 02/01/2007 | US20070026496 Process for Producing Polypeptides |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026491 Nucleotide sequences coding cytosine deaminase with enhanced ability to convert 5-fluorocytosine to its toxic form for use in treatment of cancer; antitumor agents |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026474 provides highly purified polypeptides and antibodies for use in accurate assays |
| 02/01/2007 | US20070026471 Glypican-1 in human breast cancer |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026468 Tetrameric antibody complexes for blocking non-specific labeling of antigens |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026455 Method of producing hybridoma and utilization thereof |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026448 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026395 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
| 02/01/2007 | US20070026021 Proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences; proteins are predicted to be useful antigens for vaccines and/or diagnostics; provides Neisserial DNA sequences which encode proteins that are antigenic or immunogenic |
| 02/01/2007 | US20070026018 Methods for treating, preventing and diagnosing Helicobacter infection |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070026003 Monoclonal antibodies; HCV enveloped subviral or purified HCV enveloped complete viral particles; hybridoma |
| 02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
| 02/01/2007 | US20070026000 APO-2L receptor agonist and CPT-11 synergism |
| 02/01/2007 | US20070025999 Treatment with anti-vegf antibodies |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
| 02/01/2007 | US20070025995 Taxoid derivative covalently linked to tumor-specific antibody and a method for preparing the same |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025992 Monoclonal antibody against platelet membrane glycoprotein VI |
| 02/01/2007 | US20070025991 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 02/01/2007 | US20070025990 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| 02/01/2007 | US20070025989 Administration of agents for the treatment of inflammation |
| 02/01/2007 | US20070025988 Method for Treating Lupus |
| 02/01/2007 | US20070025985 Immunoglobulins devoid of light chains |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025983 Compounds capable of inhibiting HIV-1 infection |
| 02/01/2007 | US20070025981 Microorganisms for therapy |
| 02/01/2007 | US20070025962 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/01/2007 | US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 02/01/2007 | US20070025959 Adjuvant combination formulations |
| 02/01/2007 | US20070025915 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | US20070025912 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 02/01/2007 | US20070025911 Breast cancer; hybridomas; cell lines; kits |
| 02/01/2007 | CA2616521A1 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 02/01/2007 | CA2616395A1 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 02/01/2007 | CA2616099A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/01/2007 | CA2615983A1 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 02/01/2007 | CA2615615A1 Anti-cd26 antibodies and methods of use thereof |
| 02/01/2007 | CA2614082A1 Compositions and methods for protein deaggregation |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | EP1748065A2 Cell cycle progression proteins |
| 01/31/2007 | EP1747784A1 Target gene mimitin of myc |
| 01/31/2007 | EP1747464A1 Methods for diagnosis of acute myeloid leukemia |
| 01/31/2007 | EP1747262A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 01/31/2007 | EP1747237A2 Fc gamma riib-specific antibodies and methods of use thereof |
| 01/31/2007 | EP1747015A2 Solution phase biopanning method using engineered decoy proteins |
| 01/31/2007 | EP1746985A2 Method for augmenting the effects of serotonin reuptake inhibitors |
| 01/31/2007 | EP1240519B1 Compositions and methods for detecting treponema pallidum |
| 01/31/2007 | EP1200562B1 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/31/2007 | EP1034000B1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral hiv infection |
| 01/31/2007 | CN1906300A Novel serum type streptococcus mutans and ultilization of the same |
| 01/31/2007 | CN1906299A Immunization against chlamydia infection |
| 01/31/2007 | CN1906297A IL-23 and its receptor, related reagents and methods |
| 01/31/2007 | CN1906214A Anti-IGFR1 antibody therapeutic combinations |
| 01/31/2007 | CN1906213A Interleukin-10 antibodies |
| 01/31/2007 | CN1906212A Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1906210A Surface-located campylobacter jejuni polypeptides |
| 01/31/2007 | CN1905899A EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 01/31/2007 | CN1905898A Anti-hydroxylase antibodies and uses thereof |
| 01/31/2007 | CN1905897A Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 01/31/2007 | CN1905809A Method for improving body weight uniformity and increasing carcass yield in animals |
| 01/31/2007 | CN1905806A Gel-shell beads with adsorbed or bound biomolecules |
| 01/31/2007 | CN1904041A Human recombination phospholipase D2, its preparation method and application in preparation medicine |